Izotropic Corporation, a company commercializing true 3D, dedicated breast CT imaging technology for the earlier detection of breast cancers, is pleased to announce it has partnered with EXCITE International (EXCITE), a global network of payors, health systems, patients, scientists, and end-users, to prepare for future commercial adoption of the IZOview.
With this EXCITE partnership, Izotropic will engage with EXCITE’s global network to align the device, clinical trial design, and regulatory strategy with potential payor groups, methodologists, and expert end-users.
EXCITE International is pleased to announce a new and more affordable Early Technology Review (ETR) for non-drug health technologies by excluding economic (decision analysis) modelling. Decision analysis can be undertaken if requested through our partners in the Netherlands, especially for more developed technologies and those seeking adoption in European markets.
EXCITE International wishes to announce that Naomi Aronson will be stepping down as Chair of the Payers’ Advisory Committee (PAC) effective August 31st. We are, at the same time pleased to announce that Jo Carol Hiatt, Chair of the Inter-Regional New Technology Committee at Kaiser Permanente has agreed to succeed Naomi as Chair.
EXCITE International's Payers' Advisory Committee welcomes two new members. Robert Garnett is President, Amerigroup Tennessee, part of the Medicaid Central Region and Government Business Division at Anthem, Inc. where he is responsible for the strategic, fiscal, regulatory, and operational leadership of the health plan. Stig A. Slørdahl MD, is CEO of The Central Norway Regional Health Authority. He was dean of the Faculty of Medicine at the Norwegian University of Science and Technology (NTN...
EXCITE International is pleased to announce the appointment of Jeffrey J. Popma, MD as chair of its Scientific Collaboration. This appointment follows the retirement of Dr Bryan Luce who has been chair since the inception of EXCITE International in 2016.
EXCITE International held a Health Technology Global Summit in Washington, DC in March 2019. The event was well attended and very well received. To learn more about the Summit, Read more
EXCITE International is pleased to share with you recent news highlighting the ongoing expansion and partnership development taking place in our organization. Get acquainted with our new executive board members, Sir Bruce Keogh and Carl Christian Gilhuus-Moe in addition to latest developments in our offerings, invaluable partnerships, the launch of new board committees and recent meetings and presentations.
EXCITE International’s approach to accelerating health technology innovation generated immediate interest at the 9th Annual Medical Technology Executive Forum hosted by the Medical Device Manufacturers Association (MDMA) in Palo Alto, California on September 29, 2016.
EXCITE International (Excellence in Clinical Innovation & Technology Evaluation) convened high-level health care leaders from around the world at an inaugural multijurisdictional Summit on June 2-3, 2016 in Toronto.
The inaugural meeting of the Executive Board for EXCITE International occurred in Toronto on Feb 23, 2016.
Incorporated in March 2016, EXCITE International represents a major positive disruption in the application of evidence to the evaluation of technology and has the potential to be a first-of-its kind global engine for medical technology innovation.